TB-500, the synthetic version of Thymosin Beta-4, works through an entirely different mechanism: it binds to actin (the structural protein that drives cell movement) and promotes cell migration, which is essential for tissue remodeling
It is not FDA-approved for any use and is not on any FDA bulk-drug-substance compounding list
With all that being said, working with a physician, you might be looking for a BPC-157 alternative
Conflict of interest The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
It has been reported that the global age-standardized prevalence of diabetes worldwide is 6.1%, estimating 521 million individuals globally living with the disease
Be patient and resist the urge to shake it, as this can break the delicate peptide bonds